Katherine Tarlock

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Venues

Blood advances

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Katherine Tarlock, Xiaowei Liu, Charles G Minard, Emasenyie A Isikwei, Joel M Reid, Terzah M Horton, Elizabeth Fox, Brenda J Weigel, Todd M Cooper
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712. Pediatric blood & cancer (2023)
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, Patrick A Brown, Elizabeth Fox, John Kim Choi, Brian T Fisher, Betsy Hirsch, Samir B Kahwash, Kelly D Getz, John E Levine, Lisa Eidenschink Brodersen, Michael R Loken, Susana Raimondi, Katherine Tarlock, Andrew C Wood, Lillian Sung, Edward Anders Kolb, Alan S Gamis, Soheil Meshinchi, Richard Aplenc
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3 /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
LaQuita M Jones, Katherine Tarlock, Todd M Cooper
Targeted Therapy in Pediatric AML: An Evolving Landscape. Paediatric drugs 23 (5) (2021)
Allison J Kaeding, Sonali P Barwe, Anilkumar Gopalakrishnapillai, Rhonda E Ries, Todd A Alonzo, Robert B Gerbing, Colin Correnti, Michael R Loken, Lisa Eidenschink Broderson, Laura Pardo, Quy H Le, Thao Tang, Amanda R Leonti, Jenny L Smith, Cassie K Chou, Min Xu, Timothy J Triche, Steven M Kornblau, E Anders Kolb, Katherine Tarlock, Soheil Meshinchi
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia. Blood advances 5 (9) (2021)
Katherine Tarlock, Adam J Lamble, Yi-Cheng Wang, Robert B Gerbing, Rhonda E Ries, Michael R Loken, Lisa Eidenschink Brodersen, Laura Pardo, Amanda Leonti, Jenny L Smith, Tiffany A Hylkema, William G Woods, Todd M Cooper, E Anders Kolb, Alan S Gamis, Richard Aplenc, Todd A Alonzo, Soheil Meshinchi
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group. Blood 138 (13) (2021)

Katherine Tarlock.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katherine Tarlock